These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32334914)

  • 1. The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL).
    Zhu B; Connolly PJ; Zhang SP; Chevalier KM; Milligan CM; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127198. PubMed ID: 32334914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of azetidine-piperazine di-amides as potent, selective and reversible monoacylglycerol lipase (MAGL) inhibitors.
    Zhu B; Connolly PJ; Zhang YM; McDonnell ME; Bian H; Lin SC; Liu L; Zhang SP; Chevalier KM; Brandt MR; Milligan CM; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127243. PubMed ID: 32527545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors.
    Bononi G; Granchi C; Lapillo M; Giannotti M; Nieri D; Fortunato S; Boustani ME; Caligiuri I; Poli G; Carlson KE; Kim SH; Macchia M; Martinelli A; Rizzolio F; Chicca A; Katzenellenbogen JA; Minutolo F; Tuccinardi T
    Eur J Med Chem; 2018 Sep; 157():817-836. PubMed ID: 30144699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel reversible monoacylglycerol lipase inhibitors via docking-based virtual screening.
    Xiong F; Ding X; Zhang H; Luo X; Chen K; Jiang H; Luo C; Xu H
    Bioorg Med Chem Lett; 2021 Jun; 41():127986. PubMed ID: 33766770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
    Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
    J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2
    Ikeda S; Sugiyama H; Tokuhara H; Murakami M; Nakamura M; Oguro Y; Aida J; Morishita N; Sogabe S; Dougan DR; Gay SC; Qin L; Arimura N; Takahashi Y; Sasaki M; Kamada Y; Aoyama K; Kimoto K; Kamata M
    J Med Chem; 2021 Aug; 64(15):11014-11044. PubMed ID: 34328319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of naphthyl amide derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.
    Yu Q; Song C; Bi L; Zhao S; Lei Q; Yang N; Chen H; Wang Y; He Y; Deng H
    Bioorg Med Chem; 2024 Sep; 111():117844. PubMed ID: 39106652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a new reversible MAGL inhibitor.
    Tuccinardi T; Granchi C; Rizzolio F; Caligiuri I; Battistello V; Toffoli G; Minutolo F; Macchia M; Martinelli A
    Bioorg Med Chem; 2014 Jul; 22(13):3285-91. PubMed ID: 24853323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, and Evaluation of Piperazinyl Pyrrolidin-2-ones as a Novel Series of Reversible Monoacylglycerol Lipase Inhibitors.
    Aida J; Fushimi M; Kusumoto T; Sugiyama H; Arimura N; Ikeda S; Sasaki M; Sogabe S; Aoyama K; Koike T
    J Med Chem; 2018 Oct; 61(20):9205-9217. PubMed ID: 30251836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Thiazole-5-carboxylate Derivatives as Selective Inhibitors of Monoacylglycerol Lipase as Target in Cancer.
    Ali MR; Kumar S; Shalmali N; Afzal O; Azim S; Chanana D; Alam O; Paudel YN; Sharma M; Bawa S
    Mini Rev Med Chem; 2019; 19(5):410-423. PubMed ID: 29962341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor.
    Granchi C; Lapillo M; Glasmacher S; Bononi G; Licari C; Poli G; El Boustani M; Caligiuri I; Rizzolio F; Gertsch J; Macchia M; Minutolo F; Tuccinardi T; Chicca A
    J Med Chem; 2019 Feb; 62(4):1932-1958. PubMed ID: 30715876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Isatin-Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
    Jaiswal S; Ayyannan SR
    ChemMedChem; 2022 Jan; 17(1):e202100559. PubMed ID: 34637598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.
    Aghazadeh Tabrizi M; Baraldi PG; Baraldi S; Ruggiero E; De Stefano L; Rizzolio F; Di Cesare Mannelli L; Ghelardini C; Chicca A; Lapillo M; Gertsch J; Manera C; Macchia M; Martinelli A; Granchi C; Minutolo F; Tuccinardi T
    J Med Chem; 2018 Feb; 61(3):1340-1354. PubMed ID: 29309142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azetidine and Piperidine Carbamates as Efficient, Covalent Inhibitors of Monoacylglycerol Lipase.
    Butler CR; Beck EM; Harris A; Huang Z; McAllister LA; Am Ende CW; Fennell K; Foley TL; Fonseca K; Hawrylik SJ; Johnson DS; Knafels JD; Mente S; Noell GS; Pandit J; Phillips TB; Piro JR; Rogers BN; Samad TA; Wang J; Wan S; Brodney MA
    J Med Chem; 2017 Dec; 60(23):9860-9873. PubMed ID: 29148769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
    Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
    Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoacylglycerol lipase (MAGL) as a promising therapeutic target.
    Gil-Ordóñez A; Martín-Fontecha M; Ortega-Gutiérrez S; López-Rodríguez ML
    Biochem Pharmacol; 2018 Nov; 157():18-32. PubMed ID: 30059673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.
    Granchi C; Rizzolio F; Palazzolo S; Carmignani S; Macchia M; Saccomanni G; Manera C; Martinelli A; Minutolo F; Tuccinardi T
    J Med Chem; 2016 Nov; 59(22):10299-10314. PubMed ID: 27809504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of monoacylglycerol lipase and fatty acid amide hydrolase by analogues of 2-arachidonoylglycerol.
    Ghafouri N; Tiger G; Razdan RK; Mahadevan A; Pertwee RG; Martin BR; Fowler CJ
    Br J Pharmacol; 2004 Nov; 143(6):774-84. PubMed ID: 15492019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study.
    Jha V; Biagi M; Spinelli V; Di Stefano M; Macchia M; Minutolo F; Granchi C; Poli G; Tuccinardi T
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33375358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.